Tryptophan and carcinogenesis: Review and update on how tryptophan may act

Nutrition and Cancer

Volumn 29, Issue 3, 1997, Pages 181-194

  Sidransky, Herschel ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; N (2 FLUORENYL)ACETAMIDE; N [4 (5 NITRO 2 FURYL) 2 THIAZOLYL]FORMAMIDE; NITROSAMINE; ORNITHINE DECARBOXYLASE; TRYPTOPHAN;

BLADDER TUMOR; BREAST CARCINOGENESIS; CARCINOGENESIS; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME INACTIVATION; EOSINOPHILIA MYALGIA SYNDROME; INGESTION; LIVER CARCINOGENESIS; LIVER METABOLISM; NONHUMAN; PYROLYSIS; REVIEW;

EID: 0031414673     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589709514623     Document Type: Review

References (134)

1. Sidransky, H: "Role of tryptophan in carcinogenesis." Adv Exp Med 206, 187-207, 1986.
2. Dunning, WF, Curtis, MR, and Maun, ME: "The effect of added dietary tryptophane on the occurrence of 2-acetylaminofluorene-induced liver and bladder cancer in rats." Cancer Res 10, 454-459, 1950.
3. Sugimura, T, Kawachi, T, Nagao, M, et al.: "Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products." Proc Jpn Acad 53, 58-61, 1977.
4. Wattenberg, LW: "Inhibitors of chemical carcinogenesis." In Environmental Carcinogenesis, P Emmelot and E Kriek (eds). Amsterdam: Elsevier/North Holland Biomedical, 1979, pp 241-264.
5. Belongia, EA, Mayeno, AN, and Osterholm, MT: "The eosinophilia-myalgia syndrome and tryptophan." Annu Rev Nutr 12, 235-256, 1992.
6. Sidransky, H: "Tryptophan. Unique action by an essential amino acid." In Nutritional Pathology. Pathobiochemistry of Dietary Imbalances, H Sidransky (ed). New York: Dekker, 1985, pp 1-62.
7. Murty, CN, Hornseth, R, Verney, E, and Sidransky, H: "Effect of tryptophan on enzymes and proteins of hepatic nuclear envelopes of rats." Lab Invest 48, 256-262, 1983.
8. Kurl, RN, Verney, E, and Sidransky, H: "Effect of tryptophan on rat hepatic nuclear poly(A)polymerase activity." Amino Acids 5, 263-271, 1993.
9. Sidransky, H, Murty, CN, and Verney, E: "Nutritional control of protein synthesis. Studies relating to tryptophan-induced stimulation of nucleocytoplasmic translocation of mRNA in rat liver." Am J Pathol 117, 298-309, 1984.
10. Kurl, RN, Barsoum, AL, and Sidransky, H: "Association of poly(A) polymerase with tryptophan receptor in rat hepatic nuclei." J Nutr Biochem 3, 366-372, 1992.
11. Sidransky, H, Murty, CN, and Verney, E: "Evidence for the role of glycosylation of proteins in the tryptophan-induced stimulation of nucleocytoplasmic translocation of mRNA in rat liver." Lab Invest 54, 93-99, 1986.
12. Kurl, RN, Verney, E, and Sidransky, H: "Tryptophan binding sites on nuclear envelopes of rat liver." Nutr Rep Int 36, 669-677, 1987.
13. Kurl, RN, Verney, E, and Sidransky, H: "Identification and immunohistochemical localization of a tryptophan binding protein in nuclear envelopes of rat liver." Arch Biochem Biophys 265, 286-293, 1988.
14. Schroder, HC, Wenger, R, Gerner, H, Reuter, P, Kuchino, Y, et al.: "Suppression of the modulatory effects of the antileukemic and anti-human immunodeficiency virus compound avarol on gene expression by tryptophan." Cancer Res 49, 2069-2076, 1989.
15. Boyland, E, Harris, J, and Horning, ES: "The induction of carcinoma of the bladder in rats with acetaminofluorene." Br J Cancer 8, 647-654, 1954.
16. Brown, R, and Price, JM: "Quantitative studies on metabolism of tryptophan in the urine of the dog, cat, and man." J Biol Chem 219, 985-997, 1956.
17. Bryan, T: "Role of tryptophan metabolites in urinary bladder cancer." Am Ind Hyg Assoc J 30, 27-34, 1969.
18. Radomski, JL, Glass, EM, and Deichmann, WB: "Transitional cell hyperplasia in the bladders of dogs fed DL-tryptophan." Cancer Res 31, 1690-1694, 1971.
19. Miyakawa, M, and Yoshida, O: "DNA synthesis of the urinary bladder epithelium in rats with long-term feeding of DL-tryptophan-added and pyridoxine-deficient diet." Gann 64, 411-413, 1973.
20. Radomski, JL, Radomski, T, and MacDonald, WE: "Cocarcinogenic interaction between DL-tryptophan and 4-aminobiphenyl or 2-naphthylamine in dogs." JNCI 58, 1831-1834, 1977.
21. Matsushima, M: "The role of tryptophan's promoting factor on tumorigenesis in the urinary bladder. 2. Urinary bladder carcinogenicity of FANFT (initiating factor) and L-tryptophan (promoting factor) in mice." Jpn J Urol 68, 731-736, 1977.
22. Cohen, SM, Arai, M, Jacobs, JB, and Friedell, GH: "Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis." Cancer Res 39, 1207-1217, 1979.
23. Fukushima, S, Friedell, GH, Jacobs, JB, and Cohen, SM: "Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide." Cancer Res 41, 3100-3103, 1981.
24. 6 deficiency on rat urinary bladder cancer promotion." Cancer Res 47, 1244-1250, 1987.
25. Sakata, T, Shirai, T, Fukushima, S, Hasegawa, R, and Ito, N: "Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats." Gann 75, 950-956, 1984.
26. Dunning, WF, and Curtis, MR: "The role of indole in incidence of 2-acetylaminofluorene-induced bladder cancer in rats." Proc Soc Exp Biol Med 99, 91-95, 1958.
27. Oyasu, R, Miller, DA, McDonald, JH, and Mass, GM: "Neoplasms of rat urinary bladder and liver: rat fed 2-acetylaminofluorene and indole." Arch Pathol 75, 184-190, 1963.
28. Oyasu, R, Baltifora, HA, Eisenstein, R, McDonald, JH, and Hass, GM: "Enhancement of tumorigenesis in the urinary bladder of rats by neonatal administration of 2-acetylaminofluorene." JNCI 40, 377-388, 1968.
29. Allen, MJ, Boyland, E, Dukes, CE, Horning, ES, and Watson, JG: "Cancer of the urinary bladder induced in mice with metabolites of aromatic amines and tryptophan." Br J Cancer 11, 212-228, 1957.
30. Clayson, DB, Jull, JW, and Bonser, GM: "The testing of ortho hydroxy-amines and related compounds by bladder implantation and a discussion of their structural requirements for carcinogenic activity." Br J Cancer 12, 222-230, 1958.
31. Bryan, GT: "The role of urinary tryptophan metabolites in the etiology of bladder cancer." Am J Clin Nutr 24, 841-846, 1971.
32. Cohen, SM, Masui, T, Garland, EM, and Arnold, LL: "Effects of diet on urinary bladder carcinogenesis and cancer prevention." J Nutr 127, 826S-829S, 1997.
33. Nagao, M, Yahagi, T, Kawachi, T, et al.: "Mutagens in foods, especially pyrolysis products of protein." In Progress in Genetic Toxicology, D Scott, BA Bridges, and FH Sobels (eds). Amsterdam: Elsevier/North Holland Biomedical, 1977, pp 259-264.
34. Hashida, C, Nagayama, K, and Takemura, N: "Induction of bladder cancer in mice by implanting pellets containing tryptophan pyrolysis products." Cancer Lett 17, 101-105, 1982.
35. Ames, BN, McCann, J, and Yamasaki, M: "Methods for detecting carcinogens and mutagens with Salmonella/mammalian-microsome mutagenicity test." Mutat Res 31, 347-364, 1975.
36. 2) by rat intestinal S9 fraction." Mutat Res 119, 103-108, 1983.
37. Mita, S, Yamazoe, T, Kamataki, T, and Kato, R: "Metabolic activation of a tryptophan pyrolysis product, 3-amino-1-methyl-5H-pyrido-(4, 3-b)-indole (Trp-P-2) by isolated rat liver nuclei." Cancer Lett 14, 261-266, 1981.
38. Yamazoe, Y, Ishii, K, Kamataki, T, Kato, R, and Sugimura, T: "Isolation and characterization of active metabolites of tryptophan-pyrolysate mutagen, Trp-P-2, formed by rat liver microsomes." Chem Biol Interact 30, 125-138, 1980.
39. Mita, S, Ishii, K, Yamazoe, Y, Kamataki, T, Sato, R, et al.: "Evidence for the involvement of N-hydroxylation of Trp-P-2 by cytochrome P-450 in the covalent binding to DNA." Cancer Res 41, 3610-3614, 1981.
40. Dunning, WF, Curtis, MR, and Maun, ME. "The effect of added dietary tryptophane on the occurrence of diethylstilbestrol-induced mammary cancer in rats." Cancer Res 10, 454-459, 1950.
41. Kawachi, T, Hirata, Y, and Sugimura, T: "Enhancement of N-nitrosodiethylamine hepatocarcinogenesis by L-tryptophan in rats." Gann 59, 523-525, 1968.
42. Okajima, E, Hiramatsu, T, Motomiya, Y, Iriya, K, and Ijuin, M: "Effect of DL-tryptophan on tumorigenesis in the urinary bladder and liver of rats treated with nitrodibutylamine." Gann 62, 163-169, 1971.
43. Evarts, RP, and Brown, CA: "Effect of L-tryptophan on diethyl-nitrosamine and 3′-methyl-4-N-dimethylaminoazobenzene hepatocarcinogenesis.′ Food Cosmetol Toxicol 15, 431-435, 1977.
44. Sidransky, H, Garrett, CT, Murty, CN, Verney, E, and Robinson, ES: "Influence of dietary tryptophan on the induction of γ-glutamyltranspeptidase positive foci in the liver of rats treated with hepatocarcinogen." Cancer Res 45, 4844-4847, 1985.
45. Takahashi, S, Lombardi, B, and Shinozuka, H: "Progression of carcinogen-induced foci of γ-glutamyltranspeptidase-positive hepatocytes to hepatomas in rat fed a choline-deficient diet." Int J Cancer 29, 445-450, 1982.
46. Shinozuka, H, and Lombardi, B: "Synergistic effect of choline-devoid diet and phenobarbital in promoting the emergence of γ-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats." Cancer Res 40, 3846-3849, 1980.
47. Sidransky, H, Verney, E, and Wang, D: "Effects of varying fat content of a high tryptophan diet on the induction of γ-glutamyltranspeptidase-positive foci in the livers of rats treated with hepatocarcinogen." Cancer Lett 31, 235-242, 1986.
48. Verney, E, Wang, D, and Sidransky, H: "Influence of level of dietary protein on tryptophan-induced promotional activity in induction of y-glutamyltranspeptidase-positive foci of rat liver." Exp Mol Pathol 47, 279-289, 1987.
49. Matsukura, N, Kawachi, T, Wakabayashi, K, Ohgaki, H, Morino, K, et al.: "Liver cancer and precancerous changes in rats induced by the basic fraction of tryptophan pyrolysate." Cancer Lett 13, 181-186, 1981.
50. Matsukura, N, Kawachi, T, Morino, K, Ohgaki, H, Sugimura, T, et al.: "Carcinogenicity in the mice of mutagenic compounds from a tryptophan pyrolysate." Science 213, 346-347, 1981.
51. Hosaka, S, Matsushima, T, Hirono, I, and Sugimura, T: "Carcinogenic activity of 3-amino-1-methyl-5H-pyrido[4, 3-b)indole (Trp-P-2), a pyrolysis product of tryptophan." Cancer Lett 13, 23-28, 1981.
52. Ishikawa, T, Takayama, S, Kitagawa, T, et al.: "In vivo experiments of tryptophan pyrolysis products." In Naturally Occurring Carcinogens - Mutagens and Modulators of Carcinogenesis, EC Miller, I Miller, T Hirono, et al. (eds). Baltimore, MD: University Park, 1979, pp 159-167.
53. Ishikawa, T, Takayama, S, Kitagawa, T, Kawachi, T, and Sugimura, T: "Induction of enzyme-altered islands in rat liver by tryptophan pyrolysis products." J Cancer Res Clin Oncol 95, 221-224, 1979.
54. Tamano, S, Tsuka, H, Tatematsu, M, Hasegawa, R, Imaida, K, et al.: "Induction of γ-glutamyltranspeptidase positive foci in rat liver by pyrolysis products of amino acids." Gann 72, 747-753, 1981.
55. National Cancer Institute. Bioassay of L-Tryptophan for Possible Carcinogenicity. Washington, DC: US Govt Printing Office, 1978. [DHEW Publ (NIH) 78-1321]
56. Miller, JA, and Miller, EC: "The metabolic activation of carcinogenic aromatic amines and amides." Prog Exp Tumor Res 11, 273-301, 1969.
57. Larsen, SS, and Williams, DE: "Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine." Drug Metab Dispos 24, 927-931, 1996.
58. Perdew, GH, and Babbs, CF: "Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol." Nutr Cancer 16, 209-218, 1991.
59. Schimke, RT, Sweeney, EW, and Berlin, CM: "The roles of synthesis and degradation in the control of rat liver tryptophan pyrrolase." J Biol Chem 240, 322-331, 1965.
60. Cihak, A: "L-Tryptophan action on hepatic RNA synthesis and enzyme induction." Mol Cell Biochem 24, 131-142, 1979.
61. Smith, SA, Marston, FAO, Dickson, AJ, and Pogson, CI: "Control of enzyme activities in rat liver by tryptophan and its metabolites." Biochem Pharmacol 28, 1645-1651, 1979.
62. Sidransky, H, Verney, E, and Murty, CN: "Effect of elevated dietary tryptophan on protein synthesis in rat liver." J Nutr 11, 1942-1948, 1981.
63. Jorgensen, JF, and Majumdar, APN: "Influence of tryptophan on the levels of hepatic microsomal cytochrome P-450 in well fed normal, adrenalectomized and phenobarbital-treated rats." Biochim Biophys Acta 444, 453-460, 1976.
64. Evarts, RP, and Mostafa, MH: "The effect of L-tryptophan and certain other ammo acids on liver nitrodimethylamine demethylase activity." Food Cosmetol Toxicol 16, 585-589, 1978.
65. Ames, BN, Swirsky Gold, L, and Willett, WC: "The causes and prevention of cancer." Proc Natl Acad Sci USA 92, 5258-5265, 1995.
66. Weisburger, JH: "Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids." Am J Clin Nutr 53, 2265-2375, 1991.
67. Christen, S, Peterhans, E, and Stocker, R: "Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory disease." Proc Natl Acad Sci USA 87, 2506-2510, 1990.
68. Farber, E: "Hepatocyte proliferation in stepwise development of experimental liver cancer." Dig Dis Sci 36, 973-978, 1991.
69. Farber, E: "Cell proliferation as a major risk factor for cancer: a concept of doubtful validity." Cancer Res 55, 3759-3762, 1995.
70. Wang, D, Verney, E, Kurl, RN, and Sidransky, H: "Effect of tryptophan on isolated hepatocytes of rats." Virchows Arch B 53, 125-132, 1987.
71. Janne, J, Holtta, E, and Guha, SK: "Polyamines in mammalian liver during growth and development." In Progress in Liver Disease, H Popper and F Schaffner (eds). New York: Grune & Stratton, 1976, vol 5, pp 100-124.
72. Boutwell, RK: "Biochemical mechanism of tumor promotion." In Carcinogenesis, JJ Slaga, A Swak, and RK Boutwell (eds). New York: Raven, 1978, vol 2, pp 49-58.
73. O'Brien, TG: "The induction of ornithine decarboxylase in an early, possibly obligatory, event in mouse skin carcinogenesis." Cancer Res 36, 2641-2653, 1976.
74. Matsuschima, M, Takano, S, Erturk, E, and Bryan, GT: "Induction of ornithine decarboxylase activity in mouse urinary bladder by L-tryptophan and some of its metabolites." Cancer Res 42, 3587-3591, 1982.
75. Sidransky, H, Murty, CN, Myers, E, and Verney, E: "Tryptophan-induced stimulation of hepatic ornithine decarboxylase activity in the rat." Exp Mol Pathol 38, 346-356, 1983.
76. Byus, CV, Costa, M, Sipes, IG, Brodie, EE, and Russell, DH: "Activation of 3′:5′-cyclic AMP-dependent protein kinase and induction of ornithine decarboxylase as early events in induction of mixed function oxygenases." Proc Natl Acad Sci USA 73, 1241-1245, 1976.
77. Russell, DH, and Levy, CC: "Polyamine accumulation and biosynthesis in a mouse L1210 leukemia." Cancer Res 31, 248-251, 1971.
78. Cavia, E, and Webb, TE: "The polyamine content in two slow-growing hepatoma." Biochem J 129, 223-224, 1972.
79. Mikol, YB, and Poirier, LA: "An inverse correlation between ornithine decarboxylase and S-adenosylmethionine in rats." Cancer Lett 13, 195-201, 1981.
80. Hopkins, FG, and Cole, SW: "On the proteid reaction of Adamkiewicz, with contributions to the chemistry of glyoxylic acid." Proc R Soc 68, 21-33, 1901.
81. Osborne, TB, and Mendel, LB: "Amino acids in nutrition and growth." J Biol Chem 17, 325-349, 1914.
82. Rose, WC, Lambert, GF, and Coon, MJ: "The amino acid requirement of man. VII. General procedures: the tryptophan requirement." J Biol Chem 211, 815-827, 1954.
83. Brown, RR: "Tryptophan metabolism - a review." In L-Tryptophan. Current Prospects in Medicine and Drug Safety, W Kochen and H Steinhart (eds). New York: de Gruyter, 1994, pp 17-30.
84. Cole, AS, and Scott, PP: "Tissue changes in the adult tryptophan-deficiency rat." Br J Nutr 8, 125-138, 1954.
85. Adamstone, FB, and Spector, H: "Tryptophan deficiency in the rat. Histologic changes induced by forced feeding of an acid hydrolyzed casein diet." Arch Pathol 49, 173-184, 1950.
86. Sidransky, H: "Chemical and cellular pathology of experimental acute amino acid deficiency." Meth Achievm Exp Pathol 6, 1-24, 1972.
87. Sidransky, H, Sarma, DSR, Bongiorno, M, and Verney, E: "Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice." J Biol Chem 243, 1123-1132, 1968.
88. Murty, CN, and Sidransky, H: "The effect of tryptophan on messenger RNA of the liver of fasted mice." Biochim Biophys Acta 262, 328-335, 1972.
89. Murty, CN, Verney, E, and Sidransky, H: "Effect of tryptophan on polyriboadenylic acid and polyadenylic acid-messenger ribonucleic acid in rat liver." Lab Invest 34, 77-85, 1976.
90. Murty, CN, Vemey, E, and Sidransky, H: "The effect of tryptophan on nucleocytoplasmic translocation of RNA in rat liver." Biochim Biophys Acta 747, 117-128, 1977.
91. Murty, CN, Verney, E, and Sidransky, H: "In vivo and in vitro studies on the effects of tryptophan on translocation of RNA from nuclei on rat liver." Biochem Med 22, 98-109, 1979.
92. Garrett, CT, Cairns, V, Murty, CN, Verney, E, and Sidransky, H: "Effect of tryptophan on informosomal and polyribosome associated messenger RNA in rat liver." J Nutr 114, 50-57, 1984.
93. Sidransky, H, Verney, E, Cosgrove, JW, Latham, R, and Mayeno, AN: "Studies of 1,1′-ethylidenebis (tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome." Toxicol Appl Pharmacol 126, 108-113, 1994.
94. Sidransky, H, Kurl, RN, Holmes, SC, and Verney, E: "Tryptophan binding to nuclei of rat liver and hepatoma." J Nutr Biochem 6, 73-79, 1995.
95. 1 and Swiss mice: insight into mechanism of tryptophan's effects." J Nutr 127, 270-275, 1997.
96. Sidransky, H, and Verney, E: "Comparative studies on tryptophan binding to hepatic nuclear envelopes in Sprague-Dawley and Lewis rats." Am J Physiol 267, R502-R507, 1994.
97. Yunis, EJ, Teague, PO, Stutman, O, and Good, RA: "The thymus, autoimmunity and the involution of the lymphoid system." In Tolerance, Autoimmunity, and Aging, MM Sigel (ed). Springfield, IL: Thomas, 1972, pp 62-119.
98. Phillips, J, Mehta, K, Fernandez, C, and Raveche, E: "The NZB mouse as a model for chronic lymphocytic leukemia." Cancer Res 52, 437-443, 1992.
99. East, J: "Immunopathology and neoplasms in New Zealand black (NZB) and SJL/J mice." Prog Exp Tumor Res 13, 84-134, 1970.
100. 1 mice." Proc Natl Acad Sci USA 91, 4062-4066, 1994.
101. Sidransky, H, and Vemey, E: "Effect of diet and tryptophan on hepatic polyribosomal disaggregation due to actinomycin D." Exp Mol Pathol 17, 233-248, 1972.
102. Sidransky, H, Murty, CN, and Verney, E: "Effect of tryptophan on the inhibitory action of selected hepatotoxic agents on hepatic protein synthesis." Exp Mol Pathol 37, 305-322, 1982.
103. Sidransky, H, Verney, E, and Murty, CN: "Effect of tryptophan on hepatic polyribosomes and protein synthesis in rats treated with carbon tetrachloride." Toxicol Appl Pharmacol 39, 295-305, 1977.
104. Wang, D, Verney, E, and Sidransky, H: "Protective effect of tryptophan and cysteine against carbon tetrachloride-induced liver injury." Exp Mol Pathol 43, 364-374, 1985.
105. Sidransky, H, Verney, E, and Sarma, DSR: "Effect of tryptophan on hepatic polyribosomal disaggregation due to ethionine." Proc Soc Exp Biol Med 140, 633-637, 1972.
106. Sarma, DSR, Bongiorno, M, Verney, E, and Sidransky, H: "Effect of oral administration of tryptophan or water on hepatic polyribosomal disaggregation due to puromycin." Exp Mol Pathol 19, 23-25, 1973.
107. Sidransky, H, Verney, E, and Murty, CN: "Effect of tryptophan on hepatic polyribosomal disaggregation due to hypertonic sodium chloride." Lab Invest 34, 291-297, 1976.
108. Sainio, EL, Pulkki, K, and Young, SN: "L-Tryptophan: biochemical, nutritional and pharmacological aspects." Amino Acids 10, 21-47, 1996.
109. Gullino, P, Winitz, M, Birnbaum, M, Cornfield, J, Otez, MC, et al.: "Studies on the metabolism of amino acids and related compounds in vivo. I. Toxicity of essential amino acids, individually and in mixtures, and the protective effect of L-arginine." Arch Biochem Biophys 64, 319-332, 1956.
110. Thompson, J, Rankin, H, Ashcroft, GW, Yates, CM, McQueen, JK, and Cumming, SW: "The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo." Psychol Med 12, 741-751, 1982.
111. Murphy, DL, Baker, M, Goodwin, FK, Miller, H, Kotin, J, et al.: "L-Tryptophan in affective disorders: indoleamine changes and differential clinical effects." Psychopharmacologia 34, 11-20, 1974.
112. Gillin, JC, Kaplan, JA, and Wyatt, RJ: "Clinical effects of tryptophan in chronic schizophrenic patients." Biol Psychiatry 11, 635-639, 1976.
113. Trilson, ME, and Sampson, HW: "Ultrastructural changes of the liver following L-tryptophan ingestion in rats." J Nutr 116, 1109-1115, 1986.
114. Matthias, DL, and Jacobs, FA: "Rat liver is not damaged by high dose tryptophan treatment." J Nutr 123, 852-859, 1993.
115. Young, SN: "Food constituents affecting normal and abnormal behaviors." In Nutrition and the Brain, RJ Wurtman and JJ Wurtman (eds). New York: Raven, 1986, vol 7, pp 49-88.
116. Sidransky, H, and Verney, E: "Effect of nutritional alterations on protein synthesis in transplantable hepatomas and host livers of rats." Cancer Res 39, 1995-2000, 1979.
117. Sidransky, H, Kurl, RN, Holmes, SC, and Vemey, E: "Tryptophan binding to nuclei of rat liver and hepatoma." J Nutr Biochem 6, 73-79, 1995.
118. Sidransky, H, Verney, E, and Murty, CN: "Effect of tryptophan on hepatoma and host liver of rats. Influence after treatment with hypertonic sodium chloride and carbon tetrachloride." Exp Mol Pathol 35, 124-136, 1981.
119. Sidransky, H, and Verney, E: "Effect of inhibitory and stimulatory agents on protein synthesis in hepatomas and host livers of rats." JNCI 63, 81-87, 1979.
120. Sidransky, H, and Verney, E: "Effect of tryptophan on livers of pregnant and lactating rats and their fetuses and pups." Proc Exp Biol Med 187, 309-314, 1988.
121. Patel, NT, Yoshida, M, and Holoubek, V: "In vitro incorporation of 3′-methyl-4-dimethylaminoazobenzene into liver nuclei and release of RNA from the nuclei." Cancer Res 41, 743-751, 1981.
122. Shearer, N, and Smuckler, EA: "A search for gene expression in RNA of primary rat hepatomas." Cancer Res 31, 2104-2109, 1971.
123. Weinberger, C, Thompson, CC, Org, EE, Lebo, R, Gruol, DJ, et al.: "The c-erb-A gene encoding thyroid hormone receptor." Nature 324, 641-646, 1986.
124. Beato, M, Herrlech, P, and Schultz, G: "Steroid hormone receptors: many actors in search of a plot." Cell 83, 851-857, 1995.
125. Sidransky, H, and Verney, E: "The presence of thiols in the hepatic nuclear binding site for L-tryptophan: studies with selenite." Nutr Res 16, 1023-1034, 1996.
126. Thompson, CC, and Evans, RM: "Transactivation by thyroid hormone receptors: functional parallels with steroid hormone receptors." Proc Natl Acad Sci USA 86, 3494-3498, 1989.
127. Sidransky, H, Wagner, BP, and Morris, HP: "Sex differences in liver tumorigenesis in rats ingesting N-2-fluorenylacetamide." JNCI 26, 151-157, 1961.
128. Kapoor, RK, Kuksis, A, Farber, E, and Ghoshal, AK: "Alterations in hepatic nuclear membranes during hepatocarcinogenesis induced by a diet devoid of choline" (abstr). Proc Am Assoc Cancer Res 29, 150, 1988.
129. Ghoshal, AK, and Farber, E: "Induction of liver cancer by a diet deficient in methionine and choline." Carcinogenesis 5, 1367-1370, 1984.
130. Takahashi, S, Lombardi, B, and Shinozuka, H: "Progression of carcinogen-induced foci of γ-glutamyltranspeptidase-positive hepatocytes to hepatomas in rats fed a choline-deficient diet.γ Int J Cancer 29, 445-550, 1982.
131. Sidransky, H, Verney, E, and Kurl, RN: "Effect of feeding a choline-deficient diet on the hepatic nuclear response to tryptophan in the rat." Exp Mol Pathol 51, 68-79, 1989.
132. Unkila, M, Ruotsalainen, M, Pohjanovrta, R, Viluksela, M, MacDonald, E, et al.: "Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tryptophan and glucose homeostasis in the most TCDD-susceptible and the most TCDD-resistant species, guinea pigs and hamsters." Arch Toxicol 69, 677-683, 1995.
133. Sidransky, H, and Verney, E: "L-Tryptophan binding to hepatic nuclei: age and species differences." Amino Acids 12, 77-84, 1997.
134. Fernandez-Salguerao, P, Pineau, T, Hilbert, DN, McPhail, T, Lee, SST, et al.: "Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor." Science 268, 722-726, 1995.